{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:30:01Z","timestamp":1785789001410,"version":"3.56.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,9,15]]},"DOI":"10.1097\/01.tp.0000129813.54517.25","type":"journal-article","created":{"date-parts":[[2004,9,7]],"date-time":"2004-09-07T19:23:34Z","timestamp":1094585014000},"page":"755-757","source":"Crossref","is-referenced-by-count":34,"title":["Treatment of Epstein-Barr Virus Lymphoproliferative Disease after Hematopoietic Stem-Cell Transplantation with Hydroxyurea and Cytotoxic T-Cell Lymphocytes"],"prefix":"10.1097","volume":"78","author":[{"given":"Samart","family":"Pakakasama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen M.","family":"Eames","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Morriss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Helen","family":"Huls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cliona M.","family":"Rooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen E.","family":"Heslop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Krance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-22-20210129","first-page":"2208","article-title":"Risk of lymphoproliferative disorders after bone marrow transplantation: A multi-institutional study.","volume":"94","author":"Curtis","year":"1999","journal-title":"Blood"},{"key":"R2-22-20210129","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1182\/blood.V87.6.2594.bloodjournal8762594","article-title":"The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation.","volume":"87","author":"Lucas","year":"1996","journal-title":"Blood"},{"key":"R3-22-20210129","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1182\/blood.V95.4.1502.004k40_1502_1505","article-title":"CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation.","volume":"95","author":"Kuehnle","year":"2000","journal-title":"Blood"},{"issue":"suppl 1","key":"R4-22-20210129","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/annonc\/11.suppl_1.S113","article-title":"Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients.","volume":"11","author":"Milpied","year":"2000","journal-title":"Ann Oncol"},{"key":"R5-22-20210129","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood.V92.5.1549.417k32_1549_1555","article-title":"Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients.","volume":"92","author":"Rooney","year":"1998","journal-title":"Blood"},{"key":"R6-22-20210129","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0140-6736(00)02879-8","article-title":"Epstein-Barr virus-targeted therapy for AIDS-related primary lymphoma of the central nervous system.","volume":"356","author":"Slobod","year":"2000","journal-title":"Lancet"},{"key":"R7-22-20210129","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1182\/blood-2002-01-0039","article-title":"Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection.","volume":"100","author":"Savoldo","year":"2002","journal-title":"Blood"},{"key":"R8-22-20210129","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1182\/blood-2002-05-1514","article-title":"Generating CTL against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies.","volume":"101","author":"Gottschalk","year":"2003","journal-title":"Blood"},{"key":"R9-22-20210129","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm0596-551","article-title":"Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes.","volume":"2","author":"Heslop","year":"1996","journal-title":"Nat Med"},{"key":"R10-22-20210129","doi-asserted-by":"crossref","first-page":"8165","DOI":"10.1073\/pnas.89.17.8165","article-title":"Elimination of extrachromosomally amplified MYC genes from human tumor cells reduces their tumorigenicity.","volume":"89","author":"Von Hoff","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"R11-22-20210129","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1086\/515290","article-title":"Eradication of latent Epstein-Barr virus by hydroxyurea alters the growth-transformed cell phenotype.","volume":"177","author":"Chodosh","year":"1998","journal-title":"J Infect Dis"},{"key":"R12-22-20210129","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0065-230X(02)84006-4","article-title":"Treatment of Epstein-Barr virus-associated malignancies with specific T cells.","volume":"84","author":"Gottschalk","year":"2002","journal-title":"Adv Cancer Res"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.TP.0000129813.54517.25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:37:59Z","timestamp":1785785879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200409150-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,15]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.tp.0000129813.54517.25","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9,15]]}}}